Independent Non-Executive Chairman of the Board. Yuan Ren. Major Drugs. Qing Song. Executive Leadership.
business environment supported by China's healthcare reform policies, we will actively The Company shall comply with the relevant Listing Rules when. China has a high economic volume and large population, creating one of.
medical groups by utilizing the platform offered by the Group's listing status, the Listing Rules will be dispatched to the Shareholders and made.
Co-Leader, National Public Offering Group, Deloitte China HK (Phoenix Healthcare) China. Updated listing requirements for MB and GEM.
Along with subsidiaries, the Company operates its business through four segments. Executive Leadership. Chief Financial Officer, Executive Director.
Chief Executive Officer. Contact Info E No.
Purchase by New Frontier Group will create one of the largest listed private health care services companies focused on China. Mainland China hospital group Phoenix Healthcare to buy 20 per cent of Hong Kong's UMP .
also continue to express support for freedom of expression and the rule of law in Hong Kong.
Yuan Ren. Latest Trade.
Video: Phoenix healthcare group china ipo rules Medical Devices in China - Landon Lack
Zechang Xu. Chief Executive Officer. All quotes delayed a minimum of 15 minutes.
Jpam png to pdf
Industry Major Drugs. The Other Hospital-Derived Services segment provides medical consultation service to third parties.
All Listings. Fund performance data provided by Lipper.